A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trialKaoru Kubota, Satoshi Kudoh, Koichi Minato et al.|Annals of Oncology|2015Cited by 89
Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemiaAkira Yokoyama, Yoshio Honma, Junko Okabe‐Kado et al.|Blood|1996Cited by 53
Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemiaNaoki Wakimoto, Yoshio Honma, Akira Yokoyama et al.|British Journal of Cancer|1998Cited by 23
Comparison of Effective Imaging Modalities for Detecting Gastric Neoplasms: A Randomized 3-Arm Phase II TrialTomohiro Kadota, Tomonori Yano, Seiichiro Abe et al.|The American Journal of Gastroenterology|2024Cited by 21
Randomized phase III trial of S-1 plus cisplatin versus docetaxel plus cisplatin for advanced non-small-cell lung cancer (TCOG0701).Nobuyuki Katakami, Akihiko Gemma, Hiroshi Sakai et al.|Journal of Clinical Oncology|2012Cited by 17